Genefron develops and produces personal genomic diagnostic kits. The company uses gene expression signatures derived from bioinformatic developments to provide in-vitro companion diagnostics.
Genefron has fully developed diagnostic kits (CE marked and Israeli OTC) for viral and autoimmune diseases and therapies including rheumatoid arthritis, multiple sclerosis, and cytomegalovirus.